Atopic Dermatitis

This case report describes a woman with severe dermatitis, multiple allergies, and metabolic wasting syndrome.

This retrospective cohort study assesses the patient outcomes and safety of dupilumab in adults with bullous pemphigoid.

This cohort study examines the association between atopic dermatitis and inflammatory bowel disease in children and adults.

This secondary analysis of 3 randomized clinical trial evaluates the safety and efficacy of tralokinumab in older patients with moderate-to-severe atopic dermatitis.

This cross-sectional study tests and validates a model explaining the cognitive, behavioral, and disease factors associated with discordant severity grading between physicians and patients with eczema and psoriasis.

This cross-sectional study assesses the prevalence of asthma, allergic rhinitis, or atopic dermatitis among sexually diverse adults compared with heterosexual adults in the US.

This cohort study examines the risk of incident venous thromboembolism among Asian patients with atopic dermatitis.

This randomized clinical trial evaluates the efficacy and safety of interleukin-13–targeted treatment with tralokinumab monotherapy in adolescents with atopic dermatitis.

This randomized clinical trial examines the efficacy of online mindfulness and self-compassion training in addition to usual care in improving the quality of life of adults with atopic dermatitis.

This analysis of 3 randomized clinical trials assesses the efficacy and safety of upadacitinib to treat moderate-to-severe atopic dermatitis in adolescents.

This cross-sectional study of National Health Interview Survey data examines differences among sociodemographic subgroups in reported incidence of eczema in children in the US.

This post hoc analysis of 6 randomized, double-blind, placebo-controlled trials assesses the efficacy and safety of dupilumab in patients with erythrodermic atopic dermatitis.

This systematic review summarizes the values and preferences of patients and caregivers regarding the treatment of atopic dermatitis (eczema).

This cross-sectional study evaluates established comorbidities of excessive scarring in UK Biobank participants, with comparisons across ethnic groups, and identifies novel comorbidities via a phenome-wide association study.

This randomized clinical trial examines the efficacy and safety of lebrikizumab in combination with background topical corticosteroid therapy in adolescents and adults with moderate-to-severe atopic dermatitis.